Stock 1228 CANBRIDGE PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart CANbridge Pharmaceuticals Inc.

Equities

1228

KYG1821D1097

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:08 04/06/2024 BST 		5-day change 1st Jan Change
0.34 HKD +3.03% Intraday chart for CANbridge Pharmaceuticals Inc. +6.25% -65.66%
04-23 Canbridge Pharmaceuticals Shelves Glioblastoma Drug After Phase II Clinical Trials MT
04-22 CANbridge Pharmaceuticals Inc. Announces Results of CAN008 Phase II Clinical Trial for the Treatment of Glioblastoma Multiforme CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Specialty & Advanced Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CANBRIDGE PHARMACEUTICALS INC. Stock CANbridge Pharmaceuticals Inc.
 17.93M - - -
MERCK KGAA Stock Merck KGaA
 79.25B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
 9.15B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
 4.46B - -
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
 4.9B
YUHAN CORPORATION Stock Yuhan Corporation
 4.09B
  1. Stock Market
  2. Equities
  3. 1228 Stock
  4. Charts CANbridge Pharmaceuticals Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW